newsfilter
← Latest News
GlobeNewswire·

BridgeBio to Participate in November and December Investor Conferences

  • BridgeBio Pharma, Inc. announced that its management team will participate in fireside chats at four healthcare investor conferences in November & December 2026.
  • The company will present at the Jefferies Global Healthcare Conference in London on Monday, November 16 at 9:30 am GMT.
  • Presentations are scheduled for the Evercore ISI 9th Annual Healthcare Conference in Miami on Monday, November 30 at 2:35 pm EST.
  • BridgeBio will attend the Citi Global Healthcare Conference 2026 in Miami on Tuesday, December 1 at 3:00 pm EST.
  • The company will present at the Piper Sandler 38th Annual Healthcare Conference in New York on Wednesday, December 2 at 9:30 am EST.
  • Live webcasts of the presentations can be accessed via the "Events and Presentations" page on the BridgeBio investor website, with replays available for 30 days post-event.
  • BridgeBio is a commercial-stage biopharmaceutical company focused on developing transformative medicines for genetic conditions using a decentralized hub-and-spoke model.
Company
BridgeBio Pharma, Inc.
Keywords
Nasdaq:BBIO, BridgeBio Pharma, Inc.